New excipients are typically created with a specific target market and intended use in mind—often starting with oral ...
Despite the inherent variability of recombinant proteins and antibodies, biosimilars must be comparable to their ...
Virtual control groups, automation, novel excipients, and sustainability are some of the topics covered by PharmTech this ...
In this episode of Manufacturing Intelligence, we break down digital twin use in pharma, from risk reduction and scale-up ...
Todd Vaughn and Christa Myers discuss how Robotics are reshaping aseptic pharmaceutical manufacturing by improving efficiency ...
Alternative methods to the use of animals in pharmaceutical testing are becoming more used and accepted. Laura Lotfi of ...
Charles River breaks down the basics of virtual control groups in drug development.
Todd Vaughn and Christa Myers discuss how Robotics are reshaping aseptic pharmaceutical manufacturing by improving efficiency ...
Stuart Tindal and David Chau discuss spectroscopic sensor selection for continuous bioprocessing and how industry ...
In part 2 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, explains what drives the ...
Richard Sanderson, IPS, discusses pharma capital project cost pressures, bloated deliverable lists, and making the case for ...
Daniele Ansaldi, technical manager for Automated Inspection Machines at Antares Vision Group North America, outlines some of the challenges of performing visual inspections on prefilled syringes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results